Exploring Hematoma Expansion Shift With Recombinant Factor VIIa: A Pooled Analysis of 4 Randomized Controlled Trials

Keyphrases

• Absolute Growth Rate 16%
• Biological Effects 16%
• Common Odds Ratio 66%
• Growth Arrest 16%
• Growth Threshold 16%
• Hematoma Expansion 100%
• Hematoma Growth 16%
• Hemorrhage Volume 16%
• Hemostatic Therapy 16%
• Individual Patient Data 16%
• Intracerebral Hemorrhage 16%
• Large Baseline 16%
• Moderate to Severe 16%
• Percent Change 16%
• Placebo 33%
• Placebo Groups 16%
• Pooled Analysis 100%
• Randomized Controlled Trial 100%
• Recombinant Activated Factor VII (rFVIIa) 100%
• Shift Analysis 33%

Neuroscience

• Cerebral Hemorrhage 14%
• Growth Disorder 14%
• Hematoma 100%
• Placebo 42%
• Randomized Controlled Trial 100%
• Recombinant Blood Clotting Factor 7a 100%